Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionColony Group, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Colony Group, LLC closes position in GILD / Gilead Sciences, Inc.

On May 14, 2026 - Colony Group, LLC filed a 13F-HR form disclosing ownership of 0 shares of Gilead Sciences, Inc. (CH:GILD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 520,653 shares of Gilead Sciences, Inc.. This represents a change in shares of -100.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 0 -520,653 -100.00 0 -100.00
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 520,653 131,310 33.73 63,756 47.72 0.0727
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 389,343 240,095 160.87 43,161 160.83 0.0696
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 149,248 6,582 4.61 16,547 3.52 0.0358
2025-05-20 2025-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 142,666 6,522 4.79 15,986 27.12 0.0400
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 142,666 24,930 15,986 0.0400
2025-05-29 2024-12-31 13F/A-2 GILEAD SCIENCES COM 375558103 136,144 33,456 32.58 12,576 46.07 0.0327
2025-05-20 2024-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 117,736 15,048 12,576 0.0327
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 117,736 15,048 12,576 0.0327
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 102,688 -44,452 -30.21 8,609 85,990.00 0.0274
2024-08-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 147,140 84,455 134.73 10 150.00 0.0340
2024-05-16 2024-03-31 13F GILEAD SCIENCES Common 375558103 62,685 9,983 18.94 5 0.00 0.0373
2024-02-15 2023-12-31 13F GILEAD SCIENCES COM 375558103 52,702 52,702 4 0.0559
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.